2-{-3,'2-(PHENYL)-OXAZOL-4-YLMETHOXYL-CYCLOHEXYL METHOXY}-PROPIONIC ACID DERIVATIVES USED AS PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) LIGANDS FOR THE TREATMENT OF HYPERLIPIDEMIA AND DIABETES
申请人:Glombik Heiner
公开号:US20070197613A1
公开(公告)日:2007-08-23
The present invention comprises compounds and compositions for the treatment of metabolic disorders and more particularly, those insulin-related metabolic disorders of the blood such as hyperlipidemia, diabetes, insulin-resistence and the like comprising acetic acid derivatives with cyclohexylmethoxy substituents and their salts. Known as peroxisome proliferator-activated receptors (PPAR) agonists/antagonists, the invention relates to compounds of formula I
wherein the various substituent R-groups are more specifically defined herein.
Introducing two remote functional groups into rings via chain-walking represents a new strategy to efficiently access multi-substituted saturatedcyclic compounds. We report an unprecedented 1,3-cis-carboboration of cyclohexenes by nickel catalysis. The application of LiOMe as base plays a crucial role in the success of this reaction.